Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions
Chiara Guglielmi(Azienda Ospedaliera Universitaria Pisana), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Ileana Carnevali(University of Insubria), Luisa Balestrino, Stefania Tommasi(Istituto Tumori Bari), Matteo Ghilli, Francesca Spina, Gaetana Gambino(University of Pisa), Elena Tenedini(University of Modena and Reggio Emilia), Marco Marino(Istituto Oncologico Veneto), Caterina Congregati(Azienda Ospedaliera Universitaria Pisana), Francesca Bellè(Istituto di Fisiologia Clinica), Alvaro Galli(Istituto di Fisiologia Clinica), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Brunella Pilato(Istituto Tumori Bari), Margherita Patruno(Istituto Tumori Bari), Paolo Aretini(Fondazione Pisa), Enrico Tagliafico(University of Modena and Reggio Emilia), Caterina Vivanet(University of Cagliari), Elisabetta Falaschi(Azienda Ospedaliera Universitaria Pisana), Tiziana Cervelli(Istituto di Fisiologia Clinica), Eleonora Conti(Azienda Ospedaliera Universitaria Pisana), Maria Grazia Tibiletti(University of Insubria), Rosa Scarpitta(University of Pisa), Mariella Tancredi(Azienda Ospedaliera Universitaria Pisana), Cinzia Cosini(Azienda Ospedaliera Universitaria Pisana)
Cited by 9
Related Papers
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
|Nature Cell Biology|2007|979
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666